Cite

HARVARD Citation

    Mason, C. et al. (2017). Ibrutinib penetrates the blood brain barrier and shows efficacy in the therapy of Bing Neel syndrome. British journal of haematology. pp. 339-341. [Online]. 
  
Back to record